{
    "patient": {
        "Name": "Kristin Sanders",
        "DateOfBirth": "2004-03-09",
        "Sex": "Male",
        "Diagnosis": "Lobular carcinoma in situ (LCIS)",
        "BodyPart": "Breast",
        "Physician": "Dr. Beth Lopez",
        "TreatingInstitution": "Lopez, Walters and Wilson"
    },
    "specimen": {
        "Tumor specimen": {
            "source": "Breast",
            "CollectedDate": "2023-06-30",
            "ReceivedDate": "2023-07-05",
            "TumorPercentage": "31%"
        },
        "Normal specimen": {
            "source": "Blood",
            "CollectedDate": "2023-07-05",
            "ReceivedDate": "2023-07-07"
        }
    },
    "genomic variants": {
        "Somatic - Potentially Actionable": [
            {
                "Gene": "SDHA",
                "DNA Alteration": "c.1660C>T",
                "GeneMutation": "p.R554W Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "28.8%"
            },
            {
                "Gene": "IDH2",
                "DNA Alteration": "c.516G>C",
                "GeneMutation": "p.R140L Frameshift-GOF",
                "VariantAlleleFraction": "6.47%"
            }
        ],
        "Somatic - Biologically Relevant": [
            {
                "Gene": "MSH2",
                "DNA Alteration": "c.1906G>C",
                "GeneMutation": "p.R140Q Nonsense-LOF",
                "VariantAlleleFraction": "15.91%"
            },
            {
                "Gene": "HSP90B1",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.R172M Spliceregionvariant-LOF",
                "VariantAlleleFraction": "14.55%"
            },
            {
                "Gene": "KRAS",
                "DNA Alteration": "c.38_39delinsAA",
                "GeneMutation": "p.Q61P Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "4.16%"
            },
            {
                "Gene": "RNF43",
                "DNA Alteration": "c.461C>T",
                "GeneMutation": "p.Q61E Stopgain-LOF",
                "VariantAlleleFraction": "9.0%"
            }
        ],
        "Germline - Pathogenic": [],
        "Pertinent Negatives": [
            "SMO",
            "TP53"
        ]
    },
    "immunotherapy markers": [
        {
            "marker_name": "Tumor Mutational Burden",
            "TmbValue": "32 m/Mb",
            "Tmbpercentile": "90%",
            "Status type": "Microsatellite Instability Status",
            "statusvalue": "Stable"
        }
    ],
    "FDA-Approved Therapies": {
        "Current Diagnosis": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ],
        "Other Indications": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ]
    }
}